(Q37557606)

21 August 2017

1 reference

title

Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections (English)

1 reference

21 August 2017

Alex P Betrosian

1

1 reference

PubMed ID

19621991

21 August 2017

Emmanuel E Douzinas

series ordinal

2

1 reference

PubMed ID

19621991

21 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

Expert Opinion on Drug Metabolism & Toxicology

21 August 2017

1 reference

21 August 2017

5

1 reference

21 August 2017

9

1 reference

21 August 2017

1099-1112

1 reference

Bacterial resistance to beta-lactam antibiotics: compelling opportunism, compelling opportunity

21 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Beta-lactamases and beta-lactamase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Comparative Inhibition of β-Lactamases by Novel β-Lactam Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Rational antibiotic therapy and the position of ampicillin/sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Pharmacokinetics of sulbactam in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Penetration of sulbactam and ampicillin into cerebrospinal fluid of infants and young children with meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Pharmacokinetics of sulbactam and ampicillin following oral administration of sultamicillin with probenecid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Pharmacokinetics and bactericidal activity of sultamicillin in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Time-kill kinetic studies of ampicillin/sulbactam for β-Lactamase-producing enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Multiresistant Acinetobacter infections: a role for sulbactam combinations in overcoming an emerging worldwide problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Resistance to beta-lactam antibiotics: structure and mechanism based design of beta-lactamase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Beta-lactamase inhibitors: evolving compounds for evolving resistance targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Tigecycline: an expanded broad-spectrum intravenous antibiotic. Preface and summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Antimicrobial resistance in Haemophilus influenzae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Extended-spectrum beta-lactamases: a clinical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Antibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Sulbactam/ampicillin followed by oral treatment with sultamicillin for medical and surgical infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Observations on oral Sultamicillin/Unasyn CP-45 899 therapy of neonatal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Efficacy and safety of Sultamicillin (Ampicillin/Sulbactan) and Amoxicillin/Clavulanic acid in the treatment of upper respiratory tract infections in adults--an open-label, multicentric, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Practice guidelines for the diagnosis and management of skin and soft-tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Diagnosis and treatment of diabetic foot infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Guidelines for the management of adult lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Efficacy and cost of ampicillin-sulbactam and ticarcillin-clavulanate in the treatment of hospitalized patients with bacterial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Randomized comparative trial with ampicillin/sulbactam versus cefamandole in the therapy of community acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Experience with ampicillin/sulbactam in severe infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Comparison of ampicillin/sulbactam plus aminoglycoside vs. ampicillin plus clindamycin plus aminoglycoside in the treatment of intraabdominal infections in children. The Multicenter Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Ampicillin/sulbactam: current status in severe bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Probable sulbactam/ampicillin-associated prolonged cholestasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Pharmacokinetics of ampicillin and sulbactam in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425250903145251

10.1517/17425250903145251

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19621991